Fentanyl HCl Patient-Controlled lontophoretic Transdermal System for the Management of Acute Postoperative Pain

Abstract

Spanish

French

Objective:

To summarize the pharmaceutics, pharmacokinetics, development, and clinical application of IONSYS, the fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain.

Data Sources:

Clinical literature including both primary sources and review articles was accessed through a search of the MEDLINE databases (1980–October 2006). Key search terms included cutaneous analgesia, fentanyl, IONSYS, opioid, postoperative pain, and patient-controlled analgesia (PCA). Additional clinical trial and drug data were supplied by the manufacturer, the ALZA Corporation.

Study Selection and Data Extraction:

Review articles, abstracts, and clinical studies related to patient-controlled iontophoretic transdermal fentanyl and postoperative pain management were analyzed. An evaluation of the research exploring IONSYS for the management of acute postoperative pain was conducted. Relevant information was then selected and is provided in this article.

Data Synthesis:

IONSYS is the first iontophoretic transdermal drug delivery system that utilizes low-level electrical energy to actively transport ionized fentanyl HCl through intact skin. Research has revealed that use of IONSYS for patients with acute postoperative pain is safe, effective, and well tolerated. Phase I–III trials have demonstrated an appropriate dosing range leading to effective analgesia, with minimal adverse effects. The analgesia provided by this system was found to be superior to that of analgesia placebo and equivalent to that of an intravenous morphine PCA.

Conclusions:

Data from clinical trials indicated that IONSYS is successful in controlling acute postoperative pain that circumvents the limitations of intravenous patient-controlled analgesia. The use of this system may serve as an alternative modality for the management of acute pain without increasing such adverse effects as bleeding, intravenous catheter infiltration, or manual pump malfunction.

Keywords

cutaneous analgesia fentanyl IONSYS patient-controlled analgesia

Get full access to this article

View all access options for this article.

References

Woolf

. Pain: moving from symptom control towards mechanism-specific pharmacologic management. Ann Intern Med 2004;140:441-51.

Warfield

, Kahn

. Acute pain management. Programs in US hospitals and experiences and attitudes among US adults. Anesthesiology 1995;83:1090-4.

Shang

, Gan

Optimizing postoperative pain management in the ambulatory patient. Drugs 2003;63:855-67.

Rawal

Treating postoperative pain improves outcome. Minerva Anestesiol 2001;67(suppl 1):200-5.

Miaskowski

Patient-controlled modalities for acute postoperative pain management. J Perianesth Nurs 2005;20:255-67.

Carr

, Goudas

. Acute pain. Lancet 1999;353:2051-8.

Breivik

Postoperative pain management: why is it difficult to show that it improves outcome?

Eur J Anesthesiol 1998;15:748-51.

Etches

. Patient-controlled analgesia. Surg Clin North Am 1999;79:297-312.

Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. JAMA 1995;274:1874-80.

10.

Acute pain management: operative medical procedures and trauma. Public Health Service Agency for Health Care Policy and Research (PHSAHCPR). Clinical Practices Guideline no. 1. Rockville, MD: US Department of Health and Human Services, 1992.

11.

International Association for the Study of Pain, Task Force on Acute Pain. In: Ready

, Edwards

, eds. Management of acute pain: a practical guide, Seattle WA: IASP Publications, 1992.

12.

Practice guidelines for acute pain management in the perioperative setting. A report by the American Society of Anesthesiologists Task Force on Pain Management, Acute Pain Section. Anesthesiology 1995;82:1071-81.

13.

Pain assessment and management: an organizational approach. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations, 2000.

14.

Viscusi

. Emerging techniques in the treatment of postoperative pain. Am J Health Syst Pharm 2004;61(suppl):S11-4.

15.

Eade

Patient controlled analgesia—eliminating errors. Nurs Manage 1997;28:38-40.

16.

Striebel

, Toussaint

, Raab

, . Non-invasive methods for PCA in pain management. Acute Pain 1999;2:36-40.

17.

Striebel

, Oelmann

, Spies

, Rieger

, Schwagmeier

Patient-controlled intranasal analgesia: a method for noninvasive postoperative pain management. Anesth Analg 1996;83:548-51.

18.

Striebel

, Römer

, Kopf

, Schwagmeier

Patient-controlled oral analgesia with morphine. Can J Anaesth 1996;43:749-53.

19.

Peng

, Sandler

A review of the use of fentanyl in analgesia in management of acute pain in adults. Anesthesiology 1999;90:576-99.

20.

ALZA Corporation receives FDA approval for IONSYS (fentanyl iontophoretic transdermal system). The first needle-free, patient-activated analgesic system for acute postoperative pain. www.alza.com/alza/pr_1148407686 (accessed 2006 Sept 19).

21.

Willens

, Myslinski

. Pharmacodynamics, pharmacokinetics, and clinical uses of fentanyl, sufentanil, and alfentanil. Heart Lung 1993;22:239-51.

22.

Stanle

. The history and development of the fentanyl series. J Pain Symptom Manage 1992;7(suppl):S3-7.

23.

Andrews

, Prys-Roberts

Fentanyl—a review. Clinic Anaesthesiol 1983;1:97-122.

24.

Package insert. IONSYS (fentanyl iontophoretic transdermal system). Mountain View, CA: ALZA Corporation, May 2006.

25.

Halliburton

. The pharmacokinetics of fentanyl, sulfentanyl and alfentanil: a comparative review. AANA J 1988;56:299-32.

26.

Hudson

, Thomson

, Cannon

, Friesen

, Meatherall

. Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery. Anesthesiology 1986;64:334-8.

27.

Hull

, Bower

Comparative pharmacokinetics of fentanyl and alfentanil. Br J Anaesth 1982;54:871-7.

28.

Labroo

, Paine

, Thummel

, Kharasch

. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metab Disp 1997;25:1072-80.

29.

Joh

, Sila

, Bastani

Nondialyzability of fentanyl with high-efficiency and high flux membranes (letter). Anesth Analg 1998;86:447.

30.

Bastani

, Jamal

. Removal of morphine but not fentanyl during haemodialysis (letter). Nephrol Dial Transplant 1997;12:2804.

31.

Package insert. Duragesic (fentanyl). Mountain View, CA: ALZA, February 2005.

32.

Sinatra

The fentanyl HCl patient-controlled transdermal system (PCTS): an alternative to intravenous patient-controlled analgesia in the postoperative setting. Clin Pharmacokinet 2005;44(Suppl 1):1-6.

33.

Glass

, Stephen

, Jacobson

. The quantity and distribution of radiolabeled dexamethasone delivered to tissue by iontophoresis. Int J Dermatol 1980;19:519-25.

34.

Ashbum

, Streisand

, Love

, . The iontophoresis of fentanyl citrate in humans. Anesthesiology 1995;82:1146-53.

35.

Ashburn

, Stephen

, Ackerman

, . Iontophoretic delivery of morphine for postoperative analgesia. J Pain Symptom Manage 1992;7:27-33.

36.

Bertolucci

. Introduction of anti-inflammatory drugs by iontophoresis: double blind study. J Orthop Sports Phys Ther 1982;4:103-8.

37.

Gupta

, Bernstein

, Noorduin

, Van Peer

, Sathyan

, Haak

Fentanyl delivery from an electrotransport system: delivery is a function of total current, not duration of current. J Clin Pharmacol 1998;38:951-8.

38.

Sathyan

, Jaskowiak

, Evashenk

, Gupta

Characterisation of the pharmacokinetics of the fentanyl HCl patient-controlled transdermal system (PCTS): effect of current magnitude and multiple-day dosing and comparison with IV fentanyl administration. Clin Pharmacokinet 2005;44(Suppl 1):7-15.

39.

Sathyan

, Zomorodi

, Gidwani

, Gupta

The effect of dosing frequency on the pharmacokinetics of a fentanyl HCl patient-controlled transdermal system (PCTS). Clin Pharmacokinet 2005;44(Suppl 1):17-24.

40.

Gupta

, Hwang

, Southam

, Sathyan

Effects of application site and subject demographics on the pharmacokinetics of fentanyl HCl patient-controlled transdermal system (PCTS). Clin Pharmacokinet 2005;44(Suppl 1):25-32.

41.

Chelly

, Grass

, Houseman

, Minkowitz

, Pue

The safety and efficacy of a fentanyl patient-controlled transdermal system for acute postoperative analgesia: a multicenter, placebo-controlled trial. Anesth Analg 2004;98:427-33.

42.

Viscusi

, Reynolds

, Tait

, Melson

, Atkinson

. An iontophoretic fentanyl patient-activated analgesic delivery system for postoperative pain: a double-blind, placebo-controlled trial. Anesth Analg 2006;102:188-94.

43.

Viscusi

, Reynolds

, Chung

, Atkinson

, Khanna

Patient controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain. JAMA 2004;291:1333-41.

44.

Varvel

, Shafer

, Hwang

, Coen

, Stanski

. Absorption characteristics of transdermally administered fentanyl. Anesthesiology 1989;70:928-34.

45.

European Commission Approves IONSYS (fentanyl HCL iontophoretic transdermal system). First needle-free iontophoretic system for acute post-operative pain (press release). www.alza.com/alza/pr_1138640205 (accessed 2006 May 7).